DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.
about
'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIIIDetection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous SystemThe Diagnosis and Treatment of Autoimmune EncephalitisClinical Approach to Progressive Supranuclear PalsyAutoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implicationsClinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directionsNeuronal central nervous system syndromes probably mediated by autoantibodiesAutoimmune encephalitis in psychiatric institutions: current perspectivesAntibody-Mediated Autoimmune Encephalopathies and ImmunotherapiesPrednisolone and azathioprine are effective in DPPX antibody-positive autoimmune encephalitis.Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?Strategies of Functional Foods Promote Sleep in Human Being.Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum DisorderA clinical approach to diagnosis of autoimmune encephalitis.IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.Immune therapy in autoimmune encephalitis: a systematic review.Autoimmune Movement Disorders: a Clinical and Laboratory Approach.Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis.Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.Innate and adaptive immunity in human epilepsies.Predictive models in the diagnosis and treatment of autoimmune epilepsy.Progressive Encephalomyelitis with Rigidity and Myoclonus Associated With Anti-GlyR Antibodies and Hodgkin's Lymphoma: A Case Report.Anti-DPPX encephalitis: prominent nystagmus reflected by extraocular muscle FDG-PET avidity.Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons.Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.Antibody-associated CNS syndromes without signs of inflammation in the elderly.DPPX antibody-associated encephalitis: Main syndrome and antibody effects.Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies.Treatment strategies for autoimmune encephalitis.A New Classification System for IgG4 Autoantibodies.GAD65 neurological autoimmunity.Pruritus in anti-DPPX encephalitis.Pragmatic Treatment of Stiff Person Spectrum Disorders
P2860
Q22000623-8B66F9CC-B015-483A-AC81-EB0F526E157FQ26746048-655FDD2D-3FCB-4C9C-BFE9-0EB84D294426Q26769676-2651AE7D-E2B1-442D-84C8-E93382B92CDAQ26772944-92BE3179-CEC6-4826-B50F-0DBB0E5D9FFCQ26775915-E951A70A-8FC6-4F71-A333-E0880F968DBBQ26824216-442E6BE6-2715-4737-BAB8-6169243842ECQ28072253-A18B4B93-DCEE-47A5-A958-CA4D17700B52Q28079666-0A863F5A-C7DB-4173-A92F-40DD29FA19A7Q28084055-E0498703-B10C-4467-A372-130717CF95D1Q30416408-5F076F10-5DCC-41F4-B5B3-32364BC78995Q33871737-BA64F03D-01E9-40DA-839D-5E18AEE447CCQ35633066-3A09C772-2952-4AA1-A0D5-2AA267411B42Q37250508-264B1A27-9107-4198-9709-E0F0DB7FF55CQ37343730-2C08C3C8-CDC9-4935-8EB1-D2E00201E2CCQ38372686-F181ED87-8898-41CA-911B-B3C52A6C5C16Q38630867-077E56AB-20E2-40F2-8C8E-46BB87C93331Q39102143-C26E95D6-C36A-489D-B984-6D6802E30A59Q39149611-05EF717E-4A07-455F-8E5A-FCB6EB26881DQ39180685-97193349-05C5-4141-8085-5B2E698999F8Q40135696-81E3C65D-C1CE-4736-B83E-C6C154A0A118Q40181332-647A391D-4D9D-4986-BF15-92EAA6796915Q41369074-39B304C9-3623-498B-99B9-34FAD7D0DE3FQ42083017-A8E20304-24E5-4128-B46C-B5CD72111C36Q42096185-670E78DD-A0D1-4789-8147-A7E9D6C11A1EQ47623969-B854D74B-3053-4928-A138-407B1AD658F6Q47688624-0E723118-6B39-44A2-82F2-C7A23AC16740Q47786064-BC5E777A-3A11-44CC-BCD7-32E21B34031AQ48876160-08B61911-D457-42EE-A87D-BF4DBB4A71B7Q49213573-74387937-BCF3-41FF-90B0-C9DE6C37EEA9Q50327901-71473FE1-2C99-4339-B85C-9D0DF27A7F19Q51210635-B4A5506E-D8DD-444B-9C4C-2A848968D9B0Q55114040-9CB11487-5C3B-415F-B65F-0EB0DE582E9AQ58568103-3D84A99B-A8BB-4192-A462-DA496B36DA37
P2860
DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
DPPX potassium channel antibod ...... s, and outcomes in 20 patients
@nl
DPPX potassium channel antibod ...... , and outcomes in 20 patients.
@ast
DPPX potassium channel antibod ...... , and outcomes in 20 patients.
@en
type
label
DPPX potassium channel antibod ...... s, and outcomes in 20 patients
@nl
DPPX potassium channel antibod ...... , and outcomes in 20 patients.
@ast
DPPX potassium channel antibod ...... , and outcomes in 20 patients.
@en
prefLabel
DPPX potassium channel antibod ...... s, and outcomes in 20 patients
@nl
DPPX potassium channel antibod ...... , and outcomes in 20 patients.
@ast
DPPX potassium channel antibod ...... , and outcomes in 20 patients.
@en
P2093
P2860
P3181
P1433
P1476
DPPX potassium channel antibod ...... s, and outcomes in 20 patients
@en
P2093
Allen J Aksamit
Christian Probst
Claudia F Lucchinetti
Elaine C Wirrell
Joseph Y Matsumoto
Juan Pablo Appendino
Lars Komorowski
Maja Tippmann-Peikert
Paola Sandroni
Sean J Pittock
P2860
P304
P3181
P356
10.1212/WNL.0000000000000991
P407
P577
2014-10-15T00:00:00Z